drugset / Trial / NCT00003386
Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Treatment
Summary
RATIONALE: Vaccines made from tumor tissue may make the body build an immune response and kill tumor cells. PURPOSE: Phase II trial to study the effectiveness of vaccine therapy in treating patients who have stage III or stage IV ovarian epithelial cancer.
Timeline
- Start
- 1999-07
- Primary completion
- 2001-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BCG vaccine | Vaccine | — | Other |
| Subject | autologous tumor cell vaccine | Vaccine | — | Other |
| Background | Carboplatin | Small molecule | — | — |
| Background | Cisplatin | Other / unclassified | — | — |
| Background | Cyclophosphamide | Other / unclassified | — | Intravenous |
| Background | Paclitaxel | Small molecule | — | — |